TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
145,123,352
|
121,892,126
|
110,420,198 |
| Financial expenses |
1,001,464
|
364,719
|
1,017,719 |
| Earnings before taxes |
41,558,172
|
55,584,421
|
-13,807,035 |
| EBITDA |
29,167,811
|
28,022,931
|
19,746,961 |
| Total assets |
290,176,562
|
245,333,133
|
180,465,074 |
| Current assets |
41,932,909
|
24,997,037
|
22,558,886 |
| Current liabilities |
25,912,727
|
16,303,555
|
16,673,088 |
| Equity capital |
232,375,717
|
208,588,979
|
141,336,810 |
| - share capital |
1,333,987
|
1,379,619
|
1,372,551 |
| Employees (average) |
7,543
|
7,248
|
6,875 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
80.1%
|
85.0%
|
78.3% |
| Turnover per employee |
19,239
|
16,817
|
16,061 |
| Profit as a percentage of turnover |
28.6%
|
45.6%
|
-12.5% |
| Return on assets (ROA) |
14.7%
|
22.8%
|
-7.1% |
| Current ratio |
161.8%
|
153.3%
|
135.3% |
| Return on equity (ROE) |
17.9%
|
26.6%
|
-9.8% |
| Change turnover |
27,262,950
|
10,903,292
|
34,199,509 |
| Change turnover % |
23%
|
10%
|
45% |
| Chg. No. of employees |
295
|
373
|
61 |
| Chg. No. of employees % |
4%
|
5%
|
1% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.